These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38647617)

  • 21. Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents.
    Terziroli Beretta-Piccoli B; Di Bartolomeo C; Deleonardi G; Grondona AG; Silvestri T; Tesei C; Melidona L; Cerny A; Mertens J; Semmo N; Semela D; Moradpour D; Mieli-Vergani G; Vergani D; Muratori L;
    J Autoimmun; 2019 Aug; 102():89-95. PubMed ID: 31047768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laparoscopic splenectomy for patients with liver cirrhosis: Improvement of liver function in patients with Child-Pugh class B.
    Yamamoto N; Okano K; Oshima M; Akamoto S; Fujiwara M; Tani J; Miyoshi H; Yoneyama H; Masaki T; Suzuki Y
    Surgery; 2015 Dec; 158(6):1538-44. PubMed ID: 26070848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Splenic Bed Laparoscopic Splenectomy Approach for Massive Splenomegaly Secondary to Portal Hypertension and Liver Cirrhosis.
    Tian G; Li D; Yu H; Dong Y; Xue H
    Am Surg; 2018 Jun; 84(6):1033-1038. PubMed ID: 29981644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of viral eradication by direct-acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus-related compensated cirrhosis patients.
    Nagaoki Y; Imamura M; Teraoka Y; Morio K; Fujino H; Ono A; Nakahara T; Murakami E; Yamauchi M; Kawaoka T; Miki D; Tsuge M; Hiramatsu A; Hayes CN; Chayama K; Aikata H
    Hepatol Res; 2020 Nov; 50(11):1222-1233. PubMed ID: 32767446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splenectomy may improve the glomerulopathy of type II mixed cryoglobulinemia.
    Ubara Y; Hara S; Katori H; Tagami T; Kitamura A; Yokota M; Matsushita Y; Takemoto F; Yamada A; Nagahama K; Hara M; Chayama K
    Am J Kidney Dis; 2000 Jun; 35(6):1186-92. PubMed ID: 10845834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodal approach to portal hypertension and gastric varices before hepatic resection for hepatocellular carcinoma: a case report.
    Harimoto N; Araki K; Muranushi R; Hoshino K; Hagiwara K; Ishii N; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Shibuya K; Miyazaki M; Kawanaka H; Shirabe K
    Surg Case Rep; 2020 Jul; 6(1):190. PubMed ID: 32737609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Portal vein thrombosis in a patient with HCV cirrhosis and combined hemophilia A and thrombophilia V Leiden.
    Eleftheriadis N; Makris P
    Ther Clin Risk Manag; 2010 Oct; 6():539-41. PubMed ID: 21127694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of laparoscopic splenectomy on portal hypertensive gastropathy in cirrhotic patients with portal hypertension.
    Anegawa G; Kawanaka H; Uehara H; Akahoshi T; Konishi K; Yoshida D; Kinjo N; Hashimoto N; Tomikawa M; Hashizume M; Maehara Y
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1554-8. PubMed ID: 19743999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Splenectomy as therapy for esophageal varices in a myeloproliferative syndrome].
    Fockens P; Wolffenbuttel KP; van Berge Henegouwen DP; van der Heul C
    Ned Tijdschr Geneeskd; 1990 Feb; 134(6):295-7. PubMed ID: 2304591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
    Thabut D; Bureau C; Layese R; Bourcier V; Hammouche M; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle-Bladou C; Dao T; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Hillaire S; Di Martino V; Sutton A; Audureau E; Roudot-Thoraval F; Nahon P;
    Gastroenterology; 2019 Mar; 156(4):997-1009.e5. PubMed ID: 30768988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left-sided portal hypertension: Successful management by laparoscopic splenectomy following splenic artery embolization.
    Patrono D; Benvenga R; Moro F; Rossato D; Romagnoli R; Salizzoni M
    Int J Surg Case Rep; 2014; 5(10):652-5. PubMed ID: 25194596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease.
    Zaman A; Hapke R; Flora K; Rosen HR; Benner K
    Am J Gastroenterol; 1999 Nov; 94(11):3292-6. PubMed ID: 10566732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laparoscopic Splenectomy with Technical Standardization and Selection Criteria for Standard or Hand-Assisted Approach in 390 Patients with Liver Cirrhosis and Portal Hypertension.
    Kawanaka H; Akahoshi T; Kinjo N; Harimoto N; Itoh S; Tsutsumi N; Matsumoto Y; Yoshizumi T; Shirabe K; Maehara Y
    J Am Coll Surg; 2015 Aug; 221(2):354-66. PubMed ID: 26206637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of laparoscopic splenectomy on portal vein thrombosis and serum YKL-40 in patients with cirrhotic portal hypertension.
    Qi R; Jin X; Shi H; Wang C; Li H; Shi X
    Ann Hepatol; 2019; 18(6):898-901. PubMed ID: 31427175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous Clearance After Relapse Following Direct-Acting Antiviral Treatment for Chronic HCV Infection.
    Kuriry H; Casey J; Krassenburg L; La D; Kuczynski M; Shah H; Janssen HLA; Hansen BE; Feld JJ
    Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2398-2406.e1. PubMed ID: 32629131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two cases of rapid progression of esophageal varices after atezolizumab-bevacizumab treatment for hepatocellular carcinoma.
    Furusawa A; Naganuma A; Suzuki Y; Hoshino T; Yasuoka H; Tamura Y; Naruse H; Hatanaka T; Kakizaki S
    Clin J Gastroenterol; 2022 Apr; 15(2):451-459. PubMed ID: 35179703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of suspected portal-pulmonary hypertension due to hepatitis C virus infection.
    Miyasaka A; Yoshida Y; Suzuki A; Ueda H; Morino Y; Takikawa Y
    Clin J Gastroenterol; 2020 Feb; 13(1):90-96. PubMed ID: 31292842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of laparoscopic splenectomy and azygoportal disconnection on liver synthesis function and cirrhosis: a 2-year prospective study.
    Bai DS; Zhou BH; Qian JJ; Zhang C; Jin SJ; Jiang GQ
    Surg Endosc; 2020 Nov; 34(11):5074-5082. PubMed ID: 31820157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct-acting antiviral therapy for hepatitis C: The initial experience of the University of Cape Town/Groote Schuur Hospital Liver Clinic, South Africa.
    Sonderup MW; Gogela N; Nordien R; Smuts H; Korsman S; Hardie D; Spearman CW
    S Afr Med J; 2020 Jan; 110(2):112-117. PubMed ID: 32657680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of sustained virologic response in regression of portal hypertension in Egyptian patients with hepatitis C virus-associated cirrhosis and portal hypertension.
    Faheem HA; Abdulmeged NA; Hussein HA; Elmoursi AA; Elnaggar HTMY; Ghait RS
    Egypt Liver J; 2022; 12(1):27. PubMed ID: 35433052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.